Provided by Tiger Trade Technology Pte. Ltd.

Lyell Immunopharma, Inc.

14.53
-0.0800-0.55%
Pre-market: 14.650.1202+0.83%04:06 EDT
Volume:78.12K
Turnover:1.13M
Market Cap:356.05M
PE:-1.23
High:14.78
Open:14.56
Low:14.06
Close:14.61
52wk High:45.00
52wk Low:10.76
Shares:24.50M
Float Shares:10.79M
Volume Ratio:0.85
T/O Rate:0.72%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-11.8281
EPS(LYR):-16.0562
ROE:-93.28%
ROA:-34.18%
PB:1.52
PE(LYR):-0.90

Loading ...

Feb 28, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Nov 21, 2023

Major Issues Report

Form 8-K - Current report
Nov 08, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 08, 2023

Major Issues Report

Form 8-K - Current report
Sep 11, 2023

Major Issues Report

Form 8-K - Current report
Aug 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 08, 2023

Major Issues Report

Form 8-K - Current report
Aug 08, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 22, 2023

Major Issues Report

Form 8-K - Current report
Jun 06, 2023

Major Issues Report

Form 8-K - Current report
May 04, 2023

Major Issues Report

8-K - Current report